Relationship between vasomotor symptoms and metabolic syndrome in postmenopausal women

Sena Sayan, Tanju Pekin, Begüm Yıldızhan, Sena Sayan, Tanju Pekin, Begüm Yıldızhan

Abstract

Objective This study was performed to compare the vasomotor symptoms and bone mineral density of postmenopausal women with and without metabolic syndrome. Methods We performed a cross-sectional study of 200 postmenopausal women attending routine health check-ups at Marmara Faculty of Medicine Pendik Training and Research Hospital from June 2015 to December 2015. The vasomotor symptoms scored were hot flashes and night sweats. Metabolic syndrome was defined using the consensus criteria of the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute. Results Women with vasomotor symptoms had no metabolic syndrome and were younger than those without vasomotor symptoms. There was no significant difference in vasomotor symptoms between patients with osteopenia in the femoral neck, total femur, and spine and patients with normal bone mineral density. The vasomotor symptoms were similar between smokers and nonsmokers. Conclusion The presence of metabolic symptoms is inversely associated with metabolic syndrome in postmenopausal women. Lipid abnormalities and a high body mass index may be important metabolic components associated with these symptoms. No relationship is present between vasomotor symptoms and the bone mineral density of the spine, femoral neck, and total femur.

Keywords: Menopause; bone mineral density; hot flashes; metabolic syndrome; night sweats; vasomotor symptoms.

References

    1. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med 2006; 355: 2338–2347. PubMed PMID: 17135587.
    1. Reid R, Abramson BL, Blake J, et al. Managing menopause. J Obstet Gynaecol Can 2014; 36: 830–838 [in French, English abstract]. PubMed PMID: 25222364.
    1. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83–90. PubMed PMID: 8457253.
    1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–2497. PubMed PMID: 11368702.
    1. Kozan O, Oguz A, Abaci A, et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007; 61: 548–553. PubMed PMID: 17119546.
    1. Freeman EW, Sammel MD, Lin H, et al. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol 2011; 117: 1095–1104. PMID: 21508748
    1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645. PubMed PMID: 19805654.
    1. Jouyandeh Z, Nayebzadeh F, Qorbani M, et al. Metabolic syndrome and menopause. J Diabetes Metab Disord 2013; 12: 1. PubMed PMID: 23497470. Pubmed Central PMCID: PMC3598172.
    1. Joo JK, Hong GP, Han SE, et al. The association between serum uric acid level and incidence of metabolic syndrome according to menopausal status in Korean women. J Menopausal Med 2014; 20: 126–132. PubMed PMID: 25580424. Pubmed Central PMCID: PMC4286657.
    1. Ozelci R, Dilbaz B, Ozkaya E, et al. Association between bone mineral density and metabolic syndrome in Turkish women who were postmenopausal. Int J Gynaecol Obstet 2016; 133: 370–374. PubMed PMID: 26868072.
    1. von Muhlen D, Safii S, Jassal SK, et al. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo study. Osteoporos Int 2007; 18: 1337–1344. PubMed PMID: 17492393.
    1. Hwang DK, Choi HJ. The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int 2010; 21: 425–431.
    1. Kim H, Oh HJ, Choi H, et al. The association between bone mineral density and metabolic syndrome: a Korean population-based study. J Bone Miner Metab 2013; 31: 571–578.
    1. Kinjo M, Setoguchi S, Solomon DH. Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J Clin Endocrinol Metab 2007; 92: 4161–4164. PubMed PMID: 17785365.
    1. El Maghraoui A, Rezqi A, El Mrahi S, et al. Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women. BMC Endocr. Disord 2014; 14: 93.
    1. Tural A, Yoldemir T, Erenus M. Assessment of bone mineral density should be considered earlier in perimenopausal women with vasomotor symptoms. Int J Gynaecol Obstet 2009; 107: 114–116. PubMed PMID: 19666170.
    1. Crandall CJ, Aragaki A, Cauley JA, et al. Associations of menopausal vasomotor symptoms with fracture incidence. J Clin Endocrinol Metab 2015; 100: 524–534. PubMed PMID: 25522264. Pubmed Central PMCID: PMC4318890.
    1. Gast GC, Grobbee DE, Pop VJ, et al. Vasomotor symptoms are associated with a lower bone mineral density. Menopause 2009; 16: 231–238. PubMed PMID: 19034053.
    1. Ryu KJ, Park HT, Kwon DH, et al. Vasomotor symptoms and metabolic syndrome in Korean postmenopausal women. Menopause 2015; 22: 1239–1245. PubMed PMID: 25899005.
    1. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005; 23: 117–125. PubMed PMID: 15852197.
    1. Campagnoli C, Morra G, Belforte P, et al. Climacteric symptoms according to body weight in women of different socio-economic groups. Maturitas 1981; 3: 279–287. PubMed PMID: 7334937.
    1. Gast GC, Grobbee DE, Pop VJ, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51: 1492–1498. PubMed PMID: 18391100.
    1. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008; 15: 429–434. PubMed PMID: 18204407. Pubmed Central PMCID: PMC2875947.
    1. Gast GC, Samsioe GN, Grobbee DE, et al. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas 2010; 66: 285–290. PubMed PMID: 20400247.
    1. Park JK, Lim YH, Kim KS, et al. Body fat distribution after menopause and cardiovascular disease risk factors: Korean national health and nutrition examination survey 2010. J Womens Health (Larchmt) 2013; 22: 587–594. PubMed PMID: 23746280.
    1. Lee SW, Jo HH, Kim MR, et al. Association between menopausal symptoms and metabolic syndrome in postmenopausal women. Arch Gynecol Obstet 2012; 285: 541–548. PubMed PMID: 21853251.
    1. Cagnacci A, Cannoletta M, Palma F, et al. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric 2012; 15: 157–162. PubMed PMID: 22141325.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit